By Chuck Mikolajczak
NEW YORK (Reuters) - U.S. stock index futures were little changed on Monday after the S&P 500 suffered its worst weekly drop since May 2012 and the Dow moved into negative territory for the year on global growth concerns.
The benchmark S&P index slumped 3.1 percent last week to sit right at the 200-day moving average support level and is now down 5.2 percent from its record high set on Sept. 18. The declines were sparked by a cut in the global growth forecast by the International Monetary Fund and disappointing economic data in Europe.
A serious slowdown in the global economy could lead the U.S. Federal Reserve to delay an increase in interest rates if deemed serious enough, Fed officials said over the weekend.
Earnings season will pick up this week, with results expected from Dow components Intel
Ebola-related stocks were among the most active in premarket trade after a Texas health worker became the first person in the United States to contract the virus. She had treated a Liberian who died of the disease in Dallas last week, raising concern about how U.S. medical guidelines were breached.
Lakeland Industries
Smaller biotech names also were also up sharply after the second Ebola diagnosis, with iBio
Futures snapshot at 8:22 a.m. EDT:
* S&P 500 e-minis
* Nasdaq 100 e-minis
* Dow e-minis <1YMc1> were up 30 points, or 0.18 percent, with 50,801 contracts changing hands.
(Reporting by Chuck Mikolajczak; Editing by Lisa Von Ahn and Jeffrey Benkoe)